Elutia Inc.

ELUT Healthcare Medical Devices

In the quarter to June 2026, revenue fell 11.7%, EPS grew 26.1% and free cash flow fell 2.52%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.79 0.00 0.00%
Market cap
$34.9M
P/E
0.6×
Fwd P/E
−1.7×
Dividend yield
—
F-score
5/9
Altman Z
−4.10
Beneish M
0.81
Dividend safety
n/a
Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.56
Piotroski F-Score
— — — 4 3 2 2 2 5
P/S ratio
— 0.00 0.00 3.00 1.39 2.34 1.83 7.52 2.32
Altman Z-Score
— — — (0.53) (1.50) (3.53) (7.45) (10.90) (4.10)
P/FCF ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
— (4.07) (5.96) (1.30) (5.05) (9.27) (20.18) (29.13) (8.05)
P/Operating CF
— (7.65) (7.65) (23.85) (10.30) (10.63) (5.00) (8.87) (1.15)
Beneish M-Score
— — (3.18) (3.08) (3.15) (0.07) (5.22) (5.01) 0.81
P/B ratio
— 0.00 0.00 6.15 4.87 0.00 0.00 0.00 1.03
EV/Sales
— 0.00 0.00 2.64 1.14 3.18 2.01 8.25 1.49
EV/EBITDA
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/FCF
— (7.00) (7.00) (7.89) (3.40) (3.45) (2.25) (5.12) (0.39)
Current Ratio
— 1.36 1.01 2.23 1.82 1.19 0.73 0.69 2.22
Net Debt/EBITDA
— (3.63) (4.24) 1.60 0.62 (0.64) (0.17) (0.39) 1.51
Debt/Equity
— (0.41) (0.39) 1.16 1.37 (7.37) (0.61) (0.52) 0.00
ROE
— 23.48% 24.24% 147.81% (144.57%) (775.14%) 172.60% 127.15% (574.35%)
ROA
— (48.45%) (25.81%) (39.72%) (33.11%) (48.37%) (67.08%) (135.63%) 108.41%
ROIC
— 0.00% 0.00% (156.82%) (921.57%) (146.02%) 0.00% 0.00% 0.00%
Return on Tangible Assets
— (204.35%) (1,029.22%) (74.32%) (109.74%) (394.97%) 324.29% 492.59% 160.83%
Average Days of Receivables
— 67.32 61.50 61.28 46.18 269.16 87.90 177.52 432.90
Earnings Yield
— (6.62%) (6.62%) (230.28%) (37.46%) (59.55%) (84.80%) (56.42%) 179.71%
Free Cash Flow Yield
— (176.40%) (176.40%) (11.14%) (24.03%) (39.42%) (48.69%) (21.44%) (163.36%)
Free Cash Flow per Share
— (8.95) (12.08) (5.00) (1.51) (1.59) (1.22) (0.80) (1.13)
Book value per Share
— (68.95) (85.31) 7.30 1.29 (0.36) (2.13) (1.59) 0.67
Free Cash Flow
— (5.64) (7.80) (14.27) (15.81) (21.97) (22.11) (23.31) (46.69)
EV/EBIT
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates